Form 4: Mirum Pharmaceuticals Executive Exercises Stock Options, Sells Shares to Cover Taxes

Mirum Pharmaceuticals' Chief Medical Officer, Joanne Quan, exercised stock options and sold shares to cover tax obligations.

Summary

• Joanne Quan, Chief Medical Officer of Mirum Pharmaceuticals, exercised 12,500 restricted stock units on January 16, 2025.
• These units converted into 12,500 shares of common stock.
• On January 17, 2025, Ms. Quan sold 6,969 shares at a price of $45.86 per share.
• The sale was to cover tax withholding obligations related to the vesting of the restricted stock units.
• Following these transactions, Ms. Quan directly owns 5,649 shares of Mirum Pharmaceuticals common stock and 25,000 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to executive compensation and stock transactions, which is common in publicly traded companies.

Comparison to Industry Standards

• Stock option exercises and sales to cover taxes are standard practices for executives in publicly traded companies.
• The vesting schedule of 1/3rd per year is a common vesting structure for restricted stock units.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves a small number of shares being sold by an executive.

Key Dates

Keywords

Mirum Pharmaceuticals, stock options, restricted stock units, insider trading, Form 4, executive compensation, Joanne Quan, MIRM